Ukuze kunyuswe amanqanaba okhuseleko kulo lonke uluntu ngokuchasene nokwahluka kwe-Omicron, iKomiti eHlangeneyo yoGonyo kunye noGonyo (JCVI)1 yase-UK icebise ukuba inkqubo ye-booster kufuneka yandiswe ukuze ibandakanye bonke abantu abadala abaseleyo abaneminyaka eyi-18 nangaphezulu. I-JCVI ngaphambili yayicebise ukuba abo baneminyaka engaphezu kwama-40 kunye nabo basemngciphekweni ophezulu we-coronavirus (COVID-19) kufuneka banikwe into yokomeleza.
Eli cebiso lamva nje lenza wonke umntu oneminyaka eli-18 nangaphezulu e-UK afanelekele iidosi ze-booster kodwa ulawulo lwe-booster luya kubekwa phambili ngokweminyaka kunye neemeko zonyango, abo basemngciphekweni ophezulu baya kunikwa ukhetho. Ngendlela efanayo, amaZiko oLawulo lweSifo kunye noThintelo (CDC)2 uye wacebisa ukudubula kwe-booster kuye wonke umntu oneminyaka eyi-18 nangaphezulu ngenxa yokuvela kutshanje kwe Micron ukwahluka (B.1.1.529).
Ngapha koko, ngokwengxelo yoRhulumente wase-UK3, kukho imiqondiso yokuba Micron ukwahluka (B.1.1.529) kunokudluliselwa okuphezulu. Izitofu zokugonya zangoku zisenokungasebenzi kakhulu ngokuchasene noku eyahlukileyo. Kwakhona, ukusebenza kweRonapreve, olunye lonyango oluphambili lwe-COVID-19 olusungulwe mva nje lunokuba nefuthe. I-Ronapreve (casirivimab/imdevimab), iyeza le-antibody le-monoclonal lalifumene i-EMA4 ugunyaziso lonyango lwe-COVID-19 kutshanje nge-11 kaNovemba ka-2021.
Kwinqaku elihambelanayo, iZiko laseYurophu loThintelo lweZifo kunye noLawulo (ECDC)5 uye wachaza ukufunyanwa kwe-33 eqinisekisiweyo yamatyala e-Omicron (Ukusukela nge-29 kaNovemba ka-2021) kumazwe asibhozo e-European Union kunye ne-European Economic Area (EU / EEA) (i-Austria, iBelgium, iCzechia, iDenmark, iJamani, i-Itali, iNetherlands, iPortugal). Ezi meko zazingenazimpawu okanye zineempawu ezibuthathaka. Akukho tyala elibi okanye ukufa okuxeliweyo ukuza kuthi ga ngoku. Amatyala axelwe kumazwe asixhenxe angengawo awe-EU e-Australia, Botswana, Canada, Hong Kong, Israel, South Africa and United Kingdom.
***
Iingxelo:
- Urhulumente wase-UK. Ukhupho losasazo-ingcebiso ye-JCVI malunga nezitofu zokugonya i-COVID-19 kwabo baneminyaka eli-18 ukuya kuma-39 kunye nethamo lesibini leminyaka eyi-12 ukuya kweli-15. Iyafumaneka kwa- https://www.gov.uk/government/news/jcvi-advice-on-covid-19-booster-vaccines-for-those-aged-18-to-39-and-a-second-dose-for-ages-12-to-15
- I-CDC. Ingxelo yeMedia -CDC Yandisa iziNdumiso ze-COVID-19 ze-Booster. Ipapashwe nge-29 Novemba 2021. Ifumaneka e https://www.cdc.gov/media/releases/2021/s1129-booster-recommendations.html
- Urhulumente wase-UK. Ingxelo yomlomo kwiPalamente Isiteyitimenti somlomo ukuze kuhlaziywe ngokwahluka kwe-Omicron. Ipapashwe nge-29 Novemba 2021. Ifumaneka e https://www.gov.uk/government/speeches/oral-statement-to-update-on-the-omicron-variant
- I-COVID-19: I-EMA icebisa ukuba kugunyaziswe amayeza amabini e-monoclonal antibody https://www.ema.europa.eu/en/news/covid-19-ema-recommends-authorisation-two-monoclonal-antibody-medicines
- I-ECDC. Igumbi leendaba - uhlaziyo lwe-Epidemiological: i-Omicron variant of concern (VOC) - idatha ukususela nge-29 Novemba 2021 (12:30). Ifumaneka e https://www.ecdc.europa.eu/en/news-events/epidemiological-update-omicron-data-29-november-2021
***